HuGE Literature Finder
|
||
Records 1-11
|
Detection of Significant Association Between Variants in Cannabinoid Receptor 1 Gene ( CNR1 ) and Personality in African-American Population.
Frontiers in genetics 2018 9 199. Yao Yinghao, Xu Yi, Zhao Junsheng, Ma Yunlong, Su Kunkai, Yuan Wenji, Ma Jennie Z, Payne Thomas J, Li Ming |
|
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2016 Mar . Lazary Judit, Eszlari Nora, Juhasz Gabriella, Bagdy Gyor |
|
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2015 Oct 24 (7): 613-20. Icick Romain, Peoc'h Katell, Karsinti Emily, Ksouda Kamilla, Hajj Aline, Bloch Vanessa, Prince Nathalie, Mouly Stéphane, Bellivier Frank, Lépine Jean-Pierre, Laplanche Jean-Louis, Vorspan Floren |
|
Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment.
Psychopharmacology 2013 Jun 227 (3): 509-19. Mitjans Marina, Serretti Alessandro, Fabbri Chiara, Gastó Cristóbal, Catalán Rosa, Fañanás Lourdes, Arias Bárba |
|
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.
Journal of psychopharmacology (Oxford, England) 2012 Oct 26 (10): 1391-8. Mitjans Marina, Gastó Cristóbal, Catalán Rosa, Fañanás Lourdes, Arias Bárba |
|
Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression.
Archives of general psychiatry 2012 Jul 69 (7): 732-40. Agrawal Arpana, Nelson Elliot C, Littlefield Andrew K, Bucholz Kathleen K, Degenhardt Louisa, Henders Anjali K, Madden Pamela A F, Martin Nicholas G, Montgomery Grant W, Pergadia Michele L, Sher Kenneth J, Heath Andrew C, Lynskey Michael |
|
Serotonin transporter gene and negative life change events are associated with depressive phenotype.
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja = official journal of the Hungarian Association of Psychopharmacology 2010 Jun 12 (2): 347-54. Lazary Jud |
|
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
Pharmacological research 2010 May 61 (5): 400-4. Monteleone Palmiero, Bifulco Maurizio, Maina Giuseppe, Tortorella Alfonso, Gazzerro Patrizia, Proto Maria Chiara, Di Filippo Carmela, Monteleone Francesco, Canestrelli Benedetta, Buonerba Giovanna, Bogetto Filippo, Maj Mar |
|
CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009 Jul 34 (8): 2019-27. Juhasz Gabriella, Chase Diana, Pegg Emma, Downey Darragh, Toth Zoltan G, Stones Kathryn, Platt Hazel, Mekli Krisztina, Payton Antony, Elliott Rebecca, Anderson Ian M, Deakin J F Willi |
|
Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008 Oct 18 (10): 751-9. Domschke Katharina, Dannlowski Udo, Ohrmann Patricia, Lawford Bruce, Bauer Jochen, Kugel Harald, Heindel Walter, Young Ross, Morris Phillip, Arolt Volker, Deckert Jürgen, Suslow Thomas, Baune Bernhard |
|
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).
The pharmacogenomics journal 2005 5 (2): 135-41. Barrero F J, Ampuero I, Morales B, Vives F, de Dios Luna Del Castillo J, Hoenicka J, García Yébenes |
- Page last reviewed:Mar 1, 2018
- Page last updated:Jul 18, 2019
- Content source: